183 filings
Page 7 of 10
424B3
i98xpwgzu
17 Aug 21
Prospectus supplement
7:05am
8-K
jp69zb
17 Aug 21
Departure of Directors or Certain Officers
7:00am
424B3
k7fh6 ptz3n
12 Aug 21
Prospectus supplement
10:33am
8-K
dczaayd1whtz50i39w2
12 Aug 21
Gemini Therapeutics Reports Second Quarter 2021 Financial Results
10:20am
424B3
ja06ibm agbv2s20kw85
23 Jun 21
Prospectus supplement
8:56am
8-K
jiwqj tmutq8oybpcnc
23 Jun 21
Gemini Therapeutics Announces Initial Data from its Ongoing Phase 2a Study of GEM103 in Patients with Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
8:52am
424B3
0j9szgn34x6y7f7nl6g2
13 May 21
Prospectus supplement
7:41am
8-K
2ovfi41u98rj89em b8d
13 May 21
Gemini Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:30am
424B3
2s8h2m9lhiu 0kdigm9
12 May 21
Prospectus supplement
4:02pm
8-K
3mxwjr p63
7 May 21
Departure of Directors or Certain Officers
4:01pm
EFFECT
dj1h3hg
29 Apr 21
Notice of effectiveness
12:15am
CORRESP
sh84prrkhg4 ltn4
26 Apr 21
Correspondence with SEC
12:00am
8-K
4jpva9ca7cs
14 Apr 21
Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer
5:21pm
S-8
wo9sn ec4u022cd1vap
13 Apr 21
Registration of securities for employees
12:00am
8-K
kyxbfiy
29 Mar 21
Gemini Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update
4:46pm
8-K/A
ype wyeb8
29 Mar 21
Financial Statements and Exhibits
4:05pm
10-K
vn69yatb
29 Mar 21
Annual report
4:01pm